By activating GLP-1 receptors, retatrutide may help reduce hunger and increase feelings of fullness after eating
In the STEP 1 semaglutide substudy, for example, lean mass accounted for approximately 39 to 40 per cent of total weight loss.3 Skeletal muscle is metabolically active tissue, central to glucose disposal, insulin sensitivity and resting metabolic rate
Those are not normal goals for weight loss
This separation of pathways is what makes the theoretical combination interesting from a research perspective
What happens if a GLP-1 program does not work for me
At the 24-week mark, the mean increases in heart rate were: 1 mg dose: +4.1 bpm 4 mg dose: +6.1 bpm 8 mg dose: +7.9 bpm 12 mg dose: +7.8 bpm These increases were observed to be maximal around 24 weeks and then showed a slight attenuation, though they remained elevated above baseline for the entire 48-week study period